Unanet EVP Chris Crowder, a GovCon expert, says mentor-protégé JVs must be built with governance, financial structure and long-term strategy.

Using a tool to solve a protein's structure, for most researchers in the world of structural biology and computational chemistry, is not unlike using the Rosetta Stone to unlock the secrets of ancient ...

Add Yahoo as a preferred source to see more of our stories on Google. TOWNSEND, Tenn. (WATE) — After six years of fundraising, the Friends of the Smokies have raised enough to support their $9 million ...

Ingo Swann participated in classified experiments involving remote viewing. According to his account, he observed structures on the Moon. The grim choice facing the Trump administration: Economic or ...

The deadly mass shooting at a school in British Columbia came as Canadian authorities face significant obstacles in rolling out a nationwide firearms buyback that is mired in practical and logistical ...

An Arizona Supreme Court program allowing nonlawyers to own law firms has led to numerous consumer complaints. Several members of the program's oversight committee also have financial ties to firms ...

LAWTON, Iowa (KTIV) - Firefighters say a fire started in a burn pit and spread to two buildings near Lawton, Iowa, on Sunday, Feb. 8. According to firefighters, a fire originated in a burn pit before ...

Ex-Barrick executive to oversee mining policy, compliance Presidency gains direct control over key mining sector functions Industrial gold output down 23% in 2025 on tough rules ACCRA, Jan 22 (Reuters ...

The United States spent the 2010s incrementally upgrading bank-based magnetic-stripe cards with chips. Meanwhile, China leapfrogged the legacy card-based system by rolling out digital wallets and ...

The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...